TIM recognition of phosphatidylserine regulates innate and adaptive immunity
TIM 识别磷脂酰丝氨酸调节先天性和适应性免疫
基本信息
- 批准号:8676628
- 负责人:
- 金额:$ 117.97万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-09-30 至 2017-06-30
- 项目状态:已结题
- 来源:
- 关键词:AffectAntigen-Presenting CellsApoptoticAsthmaAtopic DermatitisBindingBiochemistryCellsCellular ImmunologyCessation of lifeCongenic MiceDiseaseDisease susceptibilityEpitopesFamilyFood HypersensitivityGene FamilyGenesGenetic PolymorphismGoalsGrantHepatitisHypersensitivityImmune ToleranceImmune responseImmunityInstructionLeadLigand BindingLigandsLiverLungModelingMolecularMolecular ImmunologyMonkeysMucosal Immune ResponsesMusNatural ImmunityPatternPattern recognition receptorPhasePhosphatidylserinesPlayProteinsReagentRheumatoid ArthritisRoleSeminalStructureSusceptibility GeneT-LymphocyteTransgenic Organismsadaptive immunityimprovedin vivo Modelkiller T cellnoveloral tolerancephosphatidylserine receptorpositional cloningprogramsrespiratorystructural biologyvirology
项目摘要
The overall goal of these studies is to understand how the HM genes regulate immune responses. The TIM
gene family, discovered by our group in 2001 using a positional cloning strategy in congenic mice, potently
regulates innate and adaptive immune responses. In the previous grant period, we showed that TIM-1 is an
important costimulatory molecule for T cells and an important susceptibility gene for atopic diseases, and that
TIM-4 and TIM-1 function as receptors for phosphatidylserine (PtdSer). a critical marker of apoptotic cells.
The current Program Project builds on these seminal findings, and consists of four interconnected and
complementary Projects focusing on different aspects of TIM interactions with PtdSer expressed by apoptotic
cells. The overall hypothesis is that the TIMs function as pattern recognition receptors that sense PtdSer as a
DAMP (damage associated molecular pattern), and that the TIMs function either to clear apoptotic cells or to
amplify immunity by responding to apoptotic/dying cells. In Project 1, we will study TIM-1 expressing
natural killer T (NKT) cells, which function to sense and become activated by apoptotic cells in the liver and
in the lungs. In Project 2, we will examine intracellular, molecular and functional consequences of PtdSer on
apoptotic cells binding to TIM molecules on antigen presenting cells (APCs) and T cells. In Project 3 we
will examine the role of TIMs in in vivo models of respiratory and oral tolerance, in which clearance of
apoptotic cells by TIM expressing APCs plays a critical role. In Project 4 we will examine the structure of
TIM proteins and the influence ofthe TIM gene polymorphisms on ligand recognition and presentation of
ligand binding epitopes.
Our Projects utilize unique reagents, including TIM specific mAbs, TIM-1 transgenic, TIM-4 transgenic and
TIM-I"'' and TIM-3"'" mice, TIM crystals, monkeys and complementary approaches involving crystallogra¿¿
phy, structural biology, virology, biochemistry as well as cellular and molecular immunology, in models of
asthma, hepatitis, respiratory tolerance and oral tolerance. Our studies will demonstrate that the T/Mgene
family evolved to sense the presence of apoptotic cells at different phases of immunity, and to play a major
role in regulating distinct compartments of mucosal immune responses by affecting cell activation, survival,
death and immune tolerance. The results of these studies will greatly impact our understanding of immunity,
and may lead to important new therapies for inflammatorv diseases, including asthma and food allergy.
RELEVANCE (See instructions):
The 7//W genes have been shown to be important disease susceptibility genes (asthma, allergy,
atopic dermatitis, food allergy and rheumatoid arthritis) and to potently regulate immune responses. We
believe that further study of these molecules will greatly improve our understanding of disease mechanisms,
and are likely to lead to novel therapies for asthma and food allergy.
这些研究的总体目标是了解HM基因如何调节免疫反应。TIM
项目成果
期刊论文数量(19)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
T-cell immunoglobulin and mucin domain 1 deficiency eliminates airway hyperreactivity triggered by the recognition of airway cell death.
- DOI:10.1016/j.jaci.2013.03.025
- 发表时间:2013-08
- 期刊:
- 影响因子:14.2
- 作者:Kim, Hye Young;Chang, Ya-Jen;Chuang, Ya-Ting;Lee, Hyun-Hee;Kasahara, David I.;Martin, Thomas;Hsu, Joyce T.;Savage, Paul B.;Shore, Stephanie A.;Freeman, Gordon J.;DeKruyff, Rosemarie H.;Umetsu, Dale T.
- 通讯作者:Umetsu, Dale T.
Structures of T Cell immunoglobulin mucin receptors 1 and 2 reveal mechanisms for regulation of immune responses by the TIM receptor family.
- DOI:10.1016/j.immuni.2007.01.014
- 发表时间:2007-03
- 期刊:
- 影响因子:32.4
- 作者:Santiago C;Ballesteros A;Tami C;Martínez-Muñoz L;Kaplan GG;Casasnovas JM
- 通讯作者:Casasnovas JM
TIM-family proteins promote infection of multiple enveloped viruses through virion-associated phosphatidylserine.
- DOI:10.1371/journal.ppat.1003232
- 发表时间:2013-03
- 期刊:
- 影响因子:6.7
- 作者:Jemielity S;Wang JJ;Chan YK;Ahmed AA;Li W;Monahan S;Bu X;Farzan M;Freeman GJ;Umetsu DT;Dekruyff RH;Choe H
- 通讯作者:Choe H
Reply to Das et al., "TIM1 (HAVCR1): an Essential 'Receptor' or an 'Accessory Attachment Factor' for Hepatitis A Virus?"
回复 Das 等人,“TIM1 (HAVCR1):甲型肝炎病毒的重要‘受体’还是‘辅助附着因子’?”
- DOI:10.1128/jvi.02040-18
- 发表时间:2019
- 期刊:
- 影响因子:5.4
- 作者:Costafreda,MariaIsabel;Kaplan,Gerardo
- 通讯作者:Kaplan,Gerardo
Innate lymphoid cells in asthma: Will they take your breath away?
- DOI:10.1002/eji.201444557
- 发表时间:2016-04
- 期刊:
- 影响因子:5.4
- 作者:Kim HY;Umetsu DT;Dekruyff RH
- 通讯作者:Dekruyff RH
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Gordon James Freeman其他文献
Gordon James Freeman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Gordon James Freeman', 18)}}的其他基金
TIM recognition of phosphatidylserine regulates innate adaptive immunity-Core B
TIM识别磷脂酰丝氨酸调节先天适应性免疫-Core B
- 批准号:
8507125 - 财政年份:2003
- 资助金额:
$ 117.97万 - 项目类别:
TIM recognition of phosphatidylserine regulates innate and adaptive immunity
TIM 识别磷脂酰丝氨酸调节先天性和适应性免疫
- 批准号:
8306825 - 财政年份:2003
- 资助金额:
$ 117.97万 - 项目类别:
TIM recognition of phosphatidylserine regulates innate adaptive immunity-Core B
TIM识别磷脂酰丝氨酸调节先天适应性免疫-Core B
- 批准号:
8831795 - 财政年份:2003
- 资助金额:
$ 117.97万 - 项目类别:
TIM recognition of phosphatidylserine regulates innate and adaptive immunity
TIM 识别磷脂酰丝氨酸调节先天性和适应性免疫
- 批准号:
8831796 - 财政年份:2003
- 资助金额:
$ 117.97万 - 项目类别:
相似海外基金
Tri-Signal Artificial Antigen Presenting Cells for Cancer Immunotherapy
用于癌症免疫治疗的三信号人工抗原呈递细胞
- 批准号:
10751133 - 财政年份:2023
- 资助金额:
$ 117.97万 - 项目类别:
Microfluidic Precision Engineered Artificial Antigen Presenting Cells for Cancer Immunotherapy
用于癌症免疫治疗的微流控精密工程人工抗原呈递细胞
- 批准号:
10696138 - 财政年份:2022
- 资助金额:
$ 117.97万 - 项目类别:
The role of microglia as antigen presenting cells in Globoid Cell Leukodystrophy
小胶质细胞作为抗原呈递细胞在球状细胞脑白质营养不良中的作用
- 批准号:
10663066 - 财政年份:2022
- 资助金额:
$ 117.97万 - 项目类别:
The role of microglia as antigen presenting cells in Globoid Cell Leukodystrophy
小胶质细胞作为抗原呈递细胞在球状细胞脑白质营养不良中的作用
- 批准号:
10537159 - 财政年份:2022
- 资助金额:
$ 117.97万 - 项目类别:
Analysis of the function of antigen-presenting cells present in the stroma of colorectal cancer and the intracellular microbiome
结直肠癌基质中抗原呈递细胞和细胞内微生物组的功能分析
- 批准号:
21K08723 - 财政年份:2021
- 资助金额:
$ 117.97万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Class II artificial antigen presenting cells for cancer immunotherapy
用于癌症免疫治疗的 II 类人工抗原呈递细胞
- 批准号:
10156950 - 财政年份:2021
- 资助金额:
$ 117.97万 - 项目类别:
The role of CX3CR1+ antigen presenting cells in T cell selection and central tolerance"
CX3CR1抗原呈递细胞在T细胞选择和中枢耐受中的作用"
- 批准号:
10631854 - 财政年份:2021
- 资助金额:
$ 117.97万 - 项目类别:
Reprogramming Cancer Cells into Antigen Presenting Cells: Cancer Vaccination with mRNA Enabled by Charge-Altering Releasable Transporters
将癌细胞重编程为抗原呈递细胞:通过改变电荷的可释放转运蛋白实现 mRNA 的癌症疫苗接种
- 批准号:
10153927 - 财政年份:2021
- 资助金额:
$ 117.97万 - 项目类别:
Class II artificial antigen presenting cells for cancer immunotherapy
用于癌症免疫治疗的 II 类人工抗原呈递细胞
- 批准号:
10331830 - 财政年份:2021
- 资助金额:
$ 117.97万 - 项目类别:
Analysis on detrimental interplay between pathogenic helper T cells, inflammatory antigen-presenting cells and disease-associated microglia in chronic pathogenesis of multiple sclerosis
多发性硬化症慢性发病机制中致病性辅助 T 细胞、炎症抗原呈递细胞和疾病相关小胶质细胞之间的有害相互作用分析
- 批准号:
20K16294 - 财政年份:2020
- 资助金额:
$ 117.97万 - 项目类别:
Grant-in-Aid for Early-Career Scientists














{{item.name}}会员




